6/23/2023Considerations for Registering Pharmaceutical Trademarks in China and ...

6/20/2023Chinese Drugmakers Showcased Clinical Progress in ADC, CAR-T and PD-1 ...

6/15/2023Health Technology Assessment to Inform Decision Making in China: Progr...

6/15/2023Use of Real-World Data to Improve Drug Coverage Decisions in China (BM...

6/15/2023How Health Technology Reassessment Can Support Disinvestment in China'...

6/13/2023Responding to Challenges in the Chinese Healthcare Market Volume Based...

6/12/2023Understanding China's Rapidly Growing Healthcare Market (China Briefin...

6/12/2023China Wakes Up to Danger From Illegal Lab Monkey Trade (Sixth Tone)

6/12/2023China's Growth as Pharmaceutical Hub for APIs to Continue (BioSpectrum...

6/9/2023May Was a Big Month for Oncology Therapies in China (PharmaDJ)

6/8/2023How China's Detailed Human Genetic Resources Rules May Impact MNC Life...

6/7/2023Chinese Drugmakers Seek to Emulate the Success of Novo Nordisk's Wegov...

6/5/2023British Businesses in China: Conditionally Optimistic for 2023 (China ...

6/5/2023AstraZeneca Defies Geopolitics to Bet on China (FT)

6/5/2023China Races into New-Generation Obesity Drug Arena with Potential Asse...

6/5/2023Chinese Pharma Performance A Mix Bag This Year as the Country Renews C...

6/1/2023The U.S.-Chinese Economic Relationship Is Changing—But Not Vanishing ...

5/30/2023China is in Danger of Growing Far Below its Potential (The Market NZZ)

5/29/2023National Value-based Pricing Negotiation for Oncology Drugs — Lessons...

5/29/2023April Sees Deals Worth $2.8B in ADCs, CAR-T Therapies and More (Pharma...

5/26/2023China's Souped-up Data Privacy Laws Deter Researchers (Nature)

5/26/2023China's Middle Class – Growth, Policy, and Consumption (China Briefin...

5/22/2023Doctor-influencers Ae Going Viral in China, Provoking Authorities (ROW...

5/19/2023An AstraZeneca Executive Said the Quiet Part about China Out Loud (Qua...

5/19/2023April Fundraising Rebounds with $315M Capital Injection to Hasten Biop...

5/19/2023CStone Breaks Up With Drugs Partner As U.S. Rollout Stalls (Bamboo Wor...

5/16/2023China's Top 10 Homegrown Novel Drugs in 2022, Vaccines and Cancer Drug...

5/15/2023China's $220 Billion Biotech Initiative Is Struggling to Take Off (Blo...

5/12/2023How China's Population Decline Will Impact Doing Business in the Count...

5/11/2023Lilly Migraine Deal Gives AffaMed New Mojo in Changing China: Video In...

Page:6/7 Total number of articles:189: [First][<<] [3] [4] [5] [6] [7] [>>] [End]